American Bio Medica Corp (ABMC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2000 | 07-2000 | 06-2000 | 04-2000 | 03-2000 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | -273 | -2,130 | N/A | N/A |
| Depreciation Amortization | 210 | 211 | 100 | N/A | 70 |
| Accounts receivable | N/A | -228 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | N/A | 158 | N/A | N/A | N/A |
| Other Working Capital | -150 | -151 | 710 | N/A | 230 |
| Other Operating Activity | -3 | 67 | 480 | 0 | 0 |
| Operating Cash Flow | $57 | $-216 | $-840 | $N/A | $300 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -10 | -18 | -140 | N/A | -130 |
| Sale Of Investment | N/A | 3 | N/A | N/A | N/A |
| Other Investing Activity | -210 | -218 | 200 | 0 | 300 |
| Investing Cash Flow | $-220 | $-233 | $60 | $N/A | $170 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | -3 | N/A | N/A | N/A |
| Dividend Paid | 0 | N/A | -1 | N/A | 0 |
| Other Financing Activity | -3 | -125 | 1,851 | 0 | -10 |
| Financing Cash Flow | $-3 | $-128 | $1,850 | $N/A | $-10 |
| Beginning Cash Position | N/A | 1,207 | 130 | N/A | N/A |
| End Cash Position | N/A | 630 | 1,200 | N/A | N/A |
| Net Cash Flow | $-166 | $-577 | $1,070 | $N/A | $460 |
| Free Cash Flow | |||||
| Operating Cash Flow | 57 | -216 | -840 | N/A | 300 |
| Capital Expenditure | N/A | -18 | N/A | N/A | N/A |
| Free Cash Flow | 57 | -234 | -840 | 0 | 300 |